Return to List

Study Summary
No. 2006-0783:.......Cancer Prevention; Endocrine; Psychosocial......Susan Peterson......Behavioral Science
.
Study Summary Title
Study Summary
Number:		2006-0783
Study Title:Psychosocial Aspects of MEN Syndromes
.
Physician New Patient Referral
Name:Susan PetersonPatients Call:800-392-1611 (in U.S.A.) 713-792-6161 (outside U.S.A.)
Dept:Behavioral ScienceReferring MD
Call:		800-392-1611 (in U.S.A.) 713-792-6161 (outside U.S.A.)
Phone:713-792-8267
Contact us about clinical trials
.
General Information
Disease Group:Cancer Prevention
Endocrine
Psychosocial		Supported By:N/A
Phase of Study:N/AReturn
Visit:		N/A
Treatment
Agents:		NoneHome Care:N/A
Treatment Loc:Only at MDACC
Estimated
Length of Stay
in Houston:		N/A
Description/
Intervention:		Unavailable
.
Study Objectives / Outcomes
The proposed cross-sectional study is intended to obtain information regarding current surveillance behaviors and other psychosocial outcomes among persons affected by the multiple endocrine neoplasia (MEN) 1 or MEN2, which are inherited conditions. Study participants will include patients who have been seen previously at MDACC for evaluation of MEN1 or MEN2, spouses/significant others and family members of MDACC MEN1 patients as well as MEN1 patients recruited through online support groups. Because this is the first time we are contacting these patients to invite them to participate in psychosocial research, the proposed study also will help us determine the feasibility of conducting similar studies in the future. We anticipate that data gathered from this study will enhance existing knowledge about the psychological and behavioral aspects of the MEN syndromes, and will inform future research efforts directed toward this understudied population.

The specific aims of the study include:
1. Profile the demographic, health-related, psychosocial and behavioral characteristics of adults with MEN1 or MEN2.
2. Evaluate MEN-specific distress as well as adherence to surveillance regimens among adults with MEN1 or MEN2, and identify associated with those outcomes.
3. Explore parents' attitudes about MEN1 predictive genetic testing in minors.
4. Identify predictors of parents' attitudes about MEN1 genetic testing in minors.
.
Study Status Information
Study Activation / Registration Date:05/30/2007
IRB Review and Approval Date:05/30/2007
Study Type:Behavioral
Recruitment Status:Open
Projected Accrual:N/A
.
Enrollment Eligibility
If you do not meet the enrollment eligibility, there may be other treatment options for you. Please Contact the Referral Office for more information.
Inclusion Criteria:1) Adults age 18 years or older, with a clinical or genetic diagnosis of MEN1 or MEN2

2) Spouse, Significant Other, or Family Member who is at least 18 years of age and who is related to an individual who is a patient at MDACC and who has been diagnosed with MEN1.

3) Ability to read and write English
Exclusion Criteria:1) Inability to be contacted via mail (i.e., no contact information on record, incorrect address)
.
Links
Registration Number: NCT00501449
Study Information on Clinical Trials Registry (clinicaltrials.gov)
Other Links:
.
Results

Return to Clinical Trials at M.D. Anderson Cancer Center